Workflow
AMC Networks Announces Any and All Exchange Offer and Consent Solicitation for its 10.25% Senior Secured Notes due 2029
Globenewswire· 2026-02-23 22:00
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- AMC Networks Inc. (the “Company” or “AMC Networks”) (Nasdaq: AMCX) today announced the commencement of an exchange offer (the “Exchange Offer”) to Eligible Holders (as defined below) to exchange any and all of its outstanding 10.25% Senior Secured Notes due 2029 (the “Old Notes”) for its newly-issued 10.50% Senior Secured Notes due 2032 (the “New Notes”), on the terms and subject to the conditions set forth in a Confidential Offering Memorandum and Consent Solicit ...
SHARC Energy Closes First Tranche of Debenture
Globenewswire· 2026-02-23 22:00
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC Energy” or the “Company") is pleased to announce that, further to its news release dated February 17, 2026, the Company has closed the first-tranche of a non-brokered private placement of unsecured convertible debentures of the Company (each, a “Debenture”) for a principal amount of $300,000 (the “Offering”). The Debentures will bear interest from their issue date at ...
AMC Networks Announces Effectiveness of Amendments to its 10.50% Senior Secured Notes due 2032 and Extension of Consent Solicitation
Globenewswire· 2026-02-23 22:00
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq: AMCX) announced today the receipt of Requisite Consents (as defined below) from holders of its existing 10.50% Senior Secured Notes due 2032 (the “Notes”) and the effectiveness of amendments to the indenture governing the Notes to (1) amend the covenant that limits restricted payments in order to permit buybacks, purchases, redemptions, retirements or other acquisitions of AMC Networks Inc.’s equity inte ...
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations 
Globenewswire· 2026-02-23 22:00
Webcast conference call to take place tomorrow, Tuesday, February 24, 2026, at 8:00am ETWAYNE, Pa., Feb. 23, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced that it will host ...
Tenaris Terminates Second Tranche of its USD 1.2 Billion Share Buyback Program
Globenewswire· 2026-02-23 21:56
Core Viewpoint - Tenaris S.A. has decided to terminate the second tranche of its Share Buyback Program effective March 3, 2026, due to market volatility and potential financial implications [1][3]. Group 1: Share Buyback Program Details - The second tranche of the Share Buyback Program was initially announced on May 27, 2025, with a total value of USD 600 million [2]. - This tranche commenced on November 3, 2025, and was scheduled to conclude by April 30, 2026 [2]. - As of the announcement, Tenaris has repurchased 29,295,219 ordinary shares at an aggregate cost of approximately USD 583.6 million, nearing the completion of its targeted repurchases [2]. Group 2: Rationale for Termination - The decision to terminate the buyback program was influenced by high market volatility, which could lead to significant additional payouts to the counterparty under the existing buyback agreement [3]. - The termination was executed following the expiration of the blackout period related to the company's annual earnings release on February 20, 2026 [3]. Group 3: Future Considerations - The board of directors of Tenaris will evaluate the possibility of pursuing additional buyback programs in the future [4].
Bimergen Energy Corporation Announces Closing of $13.6 Million Public Offering
Globenewswire· 2026-02-23 21:55
Core Viewpoint - Bimergen Energy Corporation has successfully closed a public offering of common stock and warrants, raising gross proceeds of $13.6 million to fund the development of battery energy storage projects and for working capital [1][2]. Group 1: Offering Details - The public offering price was set at $4.00 per share, with gross proceeds amounting to $13,600,000 before deducting underwriting discounts and offering expenses [1]. - Underwriters were granted a 45-day option to purchase up to an additional 200,000 shares and/or warrants to cover over-allotments [1]. - The offering included the purchase of 200,000 warrants by the underwriters as part of the partial exercise of their over-allotment option [1]. Group 2: Use of Proceeds - The proceeds from the offering will be utilized for the development of battery energy storage systems (BESS) projects and for general working capital [2]. Group 3: Company Overview - Bimergen Energy Corporation is a U.S.-based independent power producer focused on the development, ownership, and operation of standalone battery energy storage systems [5]. - The company specializes in utility-scale and distributed storage projects aimed at enhancing grid reliability, renewable energy integration, and providing flexible energy solutions [5]. - Bimergen manages the entire project lifecycle, including site selection, permitting, engineering, procurement, construction, and operations across multiple power markets in the United States [5].
Calian Appoints Will Majic as Acting Chief Financial Officer
Globenewswire· 2026-02-23 21:35
OTTAWA, Ontario, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, today announced the appointment of Will Majic as acting Chief Financial Officer, effective immediately. “Will is a proven financial leader with deep knowledge of our business and a track record of disciplined execution,” said Patrick Houston, Chief Executive Officer of Calian. “He has been instrumental ...
Smith+Nephew signs distribution agreement with SI-BONE
Globenewswire· 2026-02-23 21:30
Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced it has signed a distribution agreement with SI-BONE, focused on their innovative iFuse TORQ portfolio. This collaboration expands the Smith+Nephew portfolio offerings for percutaneous pelvic fracture fixation procedures and strengthens our position in high-frequency ...
Ryman Hospitality Properties, Inc. Reports Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-02-23 21:30
NASHVILLE, Tenn., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP), a leading lodging real estate investment trust (“REIT”) specializing in group-oriented, destination hotel assets in urban and resort markets, today reported financial results for the three and twelve months ended December 31, 2025. Fourth Quarter 2025 Highlights and Recent Developments: The Company reported all-time quarterly record consolidated revenue of $737.8 million, driven by quarterly record same-store ...
Village Farms Amends and Extends Canadian Cannabis Credit Facility 
Globenewswire· 2026-02-23 21:30
Company upsizes loan commitments by CAD $15 million and extends maturities one year to February 2029 Incremental debt capital provides flexibility for additional growth investments at rates below 6.0% VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF), today announced that on February 20, 2026 it amended and extended its Canadian cannabis credit facility by upsizing loan commitments with existing lenders by CAD $1 ...